The new cvi42 v6.4 release expands Circle CVI’s all-in-one solution, delivering advanced MR automation, comprehensive coronary plaque, PCAT, ...
The cardiac mapping devices market offers opportunities driven by rising cardiovascular diseases, an aging population, and a ...
Tempus AI recently received 510(k) clearance from the US Food and Drug Administration for an enhanced version of its AI-powered cardiac imaging platform, Tempus Pixel, enabling T1 and T2 mapping for ...
Non-invasive cardiac mapping reconstructed 3D cardiac activation and improved arrhythmia localisation. Read more about its clinical potential.
Abbott recently announced the the U.S. Food and Drug Administration (FDA) cleared the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™, which has first-of-its-kind grid configuration, designed to ...
Call us gluttons for punishment or overachievers, but interventional cardiology fellows in the United States—myself included—have been increasingly signing up for an additional year of training beyond ...
Tracking treatment response: Cardiac amyloid deposits are monitored using cardiovascular MR with extracellular volume (ECV) mapping. Scans performed at baseline (top row), and after six months (middle ...
The Ontario Prehospital Advanced Life Support (OPALS) Study tested the incremental effect on the rate of survival after out-of-hospital cardiac arrest of adding a program of advanced life support to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results